Libby sells SNCR 34.55: The results were not favorable as the addition of apatorsen did not demonstrate a survival benefit compared to the other two drugs alone.

The study is focused on evaluating apatorsen in combination with Abraxane and gemcitabine compared to Abraxane and gemcitabine alone in patients suffering from untreated metastic pancreatic cancer. The stock is trading heavily today, as 4.84 million shares have already been traded compared to an average daily trading volume of 417,083 shares. The stock is currently trading down 12.94% at $32.55 as of 11:05 AM EDT. In a research note, Baird said that Synchronoss might lose Verizon (VZ) as a cloud customer. The Motley Fool owns and recommends Synchronoss Technologies.


Katherine:
That would indeed be a troubling development, but it's just a rumor of a rumor at this point.

Pamelia:
Synchronoss was recently rumored to be the target of a generous buyout offer, but that talk lost momentum way back in July.

Nieves:
Analyst firms aren't talking about the mobile back-office technologist, and even the rumor mill is eerily quiet.

Margret:
Synchronoss hasn't issued a press release in the last two weeks, posted its most recent SEC filing last week, and isn't due to publish quarterly results until the end of October.

Soon:
The stock bounced off that 52-week low, recovering to a still-dramatic 12% plunge by noon.

Tifany:
The Company's software generates actionable intelligence through the collection, retention, and analysis of voice, fax, video, email, Internet, and data transmission from various types of communications networks.

Deirdre:
Verint Systems (NASDAQ:VRNT) ranks first with a loss of 1.09%; Cadence Design Systems (NASDAQ:CDNS) ranks second with a loss of 0.58%; and BroadSoft (NASDAQ:BSFT) ranks third trading unchanged.

Sharyl:
Synchronoss Technologies (NASDAQ: SNCR) is the mobile innovation leader that provides personal cloud solutions and software-based activation for connected devices across the globe.

Maxima:
PT from the Networked Society Stage (Booth 3673) in the Sands Expo.

Dominique:
Dozens of industry experts, reporters and analysts judged and scored hundreds of entries to determine the finalists and winners in CTIA's annual awards program.

Synchronoss Technologies (NASDAQ:SNCR)
//stockhand.net/us/?q=nasdaq%3Asncr&id=582080